CXCL9 Associated with Sustained Virological Response in Chronic Hepatitis B Patients Receiving Peginterferon Alfa-2a Therapy: A Pilot Study

BACKGROUND AND AIMS: There is lack of a practical biomarker to predict sustained virological response (SVR) in chronic hepatitis B (CHB) patients undergoing peginterferon alfa-2a (PEG-IFN). The aim of this pilot study was to identify immunological features associated with SVR. METHODS: Consecutive 7...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, I-Cheng, Huang, Yi-Hsiang, Su, Chien-Wei, Wang, Yuan-Jen, Huo, Teh-Ia, Lee, Kuei-Chuan, Lin, Han-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790882/
https://www.ncbi.nlm.nih.gov/pubmed/24124595
http://dx.doi.org/10.1371/journal.pone.0076798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790882/
https://www.ncbi.nlm.nih.gov/pubmed/24124595
http://dx.doi.org/10.1371/journal.pone.0076798

Ejemplares similares